Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
about
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's diseaseAzathioprine or 6-mercaptopurine for induction of remission in Crohn's diseaseThe pathophysiology of thrombocytopenia in chronic liver diseaseElderly patients and inflammatory bowel diseaseOptimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalUse of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityPharmacogenetics in inflammatory bowel diseaseLeucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazideMedical management of Crohn's disease: current therapy and recent advances.Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial.Inflammatory bowel disease: perioperative pharmacological considerations.Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease.Management of Crohn's disease.Outcomes after major surgery in patients with myasthenia gravis: A nationwide matched cohort study.Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.Normal response to vaccines in inflammatory bowel disease patients treated with thiopurinesImproving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and SpainAzathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopeniaThiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patientsReview article: acute severe ulcerative colitis - evidence-based consensus statements.Review article: Immunosuppressants in distal ulcerative colitis.The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Review article: monitoring for drug side-effects in inflammatory bowel disease.Review article: maintenance of remission in ulcerative colitis.Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer.Azathioprine in inflammatory bowel disease, a safe alternative?A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis.Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel diseaseGuidelines for the management of inflammatory bowel disease in adults.Immunosuppression: towards a logical approach in liver transplantation.An integrated approach to design novel therapeutic interventions for demyelinating disordersAzathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.Synergy between immunosuppressive therapy and enteral nutrition in the management of childhood Crohn's disease.
P2860
Q24197676-19C721A4-5FF3-49F4-A4E7-71F1B19557B4Q24240676-D553117B-D11D-490B-AE22-6C1757D68CA0Q26749277-843BBC7A-DE87-4F1E-A426-23915447CDF7Q26768270-144BC8CB-BC8E-4155-B35B-0C10869DE8F3Q26801119-2F5C44B8-1CAE-4B34-8C11-CBFC09B34C53Q26996946-541EA779-D991-468B-A73C-A307E2C170ADQ28115755-3FDB0FF6-804D-4D2A-960C-82CDD5A12023Q28246002-8F015F31-E197-43F8-AD4F-86D34D4672ACQ28361611-A73EE147-9BB2-4792-8A8A-82D6E2BD3FD3Q30450875-EDE7FFCD-7B00-4F9D-8587-68AAFA4C9A3DQ30481543-EF8C1406-6D0A-4EDE-AE75-57BE29898BD8Q30502980-BCB11507-94E3-46DA-9A8D-771FB432B21AQ30687155-381336F1-921D-4CC8-BF5E-F9A1BC24CBA9Q33374382-18CE6F26-5A9A-40C0-BCBE-D246FC9FAA8EQ33785519-0F58DD57-AEA1-44B2-81B2-597C1A798572Q33860313-664ED716-C9EC-4CC8-880C-A183969030CFQ33904308-7CF1AE5B-8024-4DA5-AAEC-98FF22628EFCQ33905391-0778E6B3-F0FA-4DDB-B3B4-4DB9C63FC67DQ34106796-8085D7EA-DA6B-46CC-AF18-135BED2D814BQ34173362-2CB8B1F0-E0CE-442D-B18E-6D21E191BC33Q34326911-0406FD9C-417C-4B44-B79F-BCBFFB4FCB95Q34409942-2CD8E77D-1FC1-428B-9893-40588A6DA60DQ34421471-2BBE23A2-ADC5-47BE-8BFE-2EDD9DCCC379Q34433052-9745295F-C9D1-4EFC-B18B-F36D2F906DF0Q34516280-99429790-CA1F-4947-BD13-67D342DB6B14Q34528270-99A98C08-B30A-4833-8A31-58E06D10AFB9Q34541684-D64A682F-B46C-4E47-8D00-32129C80B74BQ34559065-BB475FA2-8A97-40CA-93C5-28E3CE134F99Q34564902-A26D0A32-5714-489A-97C0-F9C0BBA88355Q34585315-442571B4-BDB9-41F0-8A07-1CC8FD547876Q34669207-42F17237-511A-41DD-A67F-5258D9A2939FQ34728470-B105812C-3BCF-4FE8-B9C8-4E6F6EA26460Q35609845-D04F50C6-8357-4E6D-AF2C-5A04CCC4E29EQ35753383-3A23A5C0-E3EE-4C3C-8E15-BF427FD927CCQ35760894-7698ED47-563B-4362-95FE-4699285AACB9Q35790559-FC4C83A9-1F87-4BE1-A121-12566A9203D0Q35987954-773256C9-3E69-45AB-B22D-8BF423FBAD7BQ36059972-1E6AE858-093C-46E8-953B-619A494A66B0Q36175167-0621FD12-F19C-46E2-B30C-1287DD203302Q36175772-00479310-C35A-4BE3-9B2B-458F6A43AC15
P2860
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Bone marrow toxicity caused by ...... sease: 27 years of experience.
@ast
Bone marrow toxicity caused by ...... sease: 27 years of experience.
@en
type
label
Bone marrow toxicity caused by ...... sease: 27 years of experience.
@ast
Bone marrow toxicity caused by ...... sease: 27 years of experience.
@en
prefLabel
Bone marrow toxicity caused by ...... sease: 27 years of experience.
@ast
Bone marrow toxicity caused by ...... sease: 27 years of experience.
@en
P2093
P2860
P921
P356
P1433
P1476
Bone marrow toxicity caused by ...... sease: 27 years of experience.
@en
P2093
P2860
P304
P356
10.1136/GUT.34.8.1081
P407
P577
1993-08-01T00:00:00Z